Insider sale
SYROS PHARMACEUTICALS, INC.
$4.9K
21.33K shares
What this filing means
FLAGSHIP VENTURELABS IV, LLC plans to sell 21.33K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $4.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/13/2024ACC: 0001968582-24-001182
21.33K
Shares to sell
$4.9K
Approx. market value
21.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Pre-IPO VC Stage Investment
Cash
6/29/2012
21.33KTotal acquired21.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/29/2012 | Pre-IPO VC Stage Investment Cash | 21.33K | — |
| Total | 21.33K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
21.33K
Market value
$4.9K
12/13/2024
Total
Units
21.33K
Value
$4.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
12/13/2024 | 21.33K | $4.9K | Nasdaq | Planned |
| Total | 21.33K | $4.9K | ||